Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation

2015, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 386, 743, 10.1016/S0140-6736(15)60692-4 Ma, 2017, Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond, Nephrol Dial Transplant, 32, i129, 10.1093/ndt/gfw336 Floege, 2019, Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, 95, 268, 10.1016/j.kint.2018.10.018 Samy, 2017, Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases, Int Rev Immunol, 36, 3, 10.1080/08830185.2016.1276903 Fellstrom, 2017, Targeted-release budesonide therapy for IgA nephropathy - authors’ reply, Lancet, 390, 2625, 10.1016/S0140-6736(17)32138-4 Kobayashi, 2009, Transactivation of RON receptor tyrosine kinase by interaction with PDGF receptor beta during steady-state growth of human mesangial cells, Kidney Int, 75, 1173, 10.1038/ki.2009.44 Meyer, 2013, The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells, Sci Signal, 6, ra66, 10.1126/scisignal.2004155 Scaltriti, 2016, Molecular pathways: AXL, a membrane receptor mediator of resistance to therapy, Clin Cancer Res, 22, 1313, 10.1158/1078-0432.CCR-15-1458 O’Bryan, 1991, AXL, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase, Mol Cell Biol, 11, 5016 Graham, 2014, The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer, Nat Rev Cancer, 14, 769, 10.1038/nrc3847 Brown, 2016, Gene of the month: Axl, J Clin Pathol, 69, 391, 10.1136/jclinpath-2016-203629 Heldin, 1999, Mechanism of action and in vivo role of platelet-derived growth factor, Physiol Rev, 79, 1283, 10.1152/physrev.1999.79.4.1283 Boor, 2014, PDGF and the progression of renal disease, Nephrol Dial Transplant, 29, i45, 10.1093/ndt/gft273 Niemir, 1995, PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis, Kidney Int, 48, 1530, 10.1038/ki.1995.443 Uehara, 2004, Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy, Clin Exp Nephrol, 8, 36, 10.1007/s10157-003-0265-8 Floege, 2008, A new look at platelet-derived growth factor in renal disease, J Am Soc Nephrol, 19, 12, 10.1681/ASN.2007050532 Nakagawa, 2012, Platelet-derived growth factor and renal disease, Curr Opin Nephrol Hypertens, 21, 80, 10.1097/MNH.0b013e32834db4d3 Doi, 1992, Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor, Proc Natl Acad Sci U S A, 89, 2873, 10.1073/pnas.89.7.2873 Johnson, 1993, Role of platelet-derived growth factor in glomerular disease, J Am Soc Nephrol, 4, 119, 10.1681/ASN.V42119 Ranieri, 2001, The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy, J Nephrol, 14, 253 Terada, 1997, Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy, J Am Soc Nephrol, 8, 817, 10.1681/ASN.V85817 Ebefors, 2016, Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1, BMC Nephrol, 17, 40, 10.1186/s12882-016-0251-5 Novak, 2011, IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells, Nephrol Dial Transplant, 26, 3451, 10.1093/ndt/gfr448 Yamada, 2017, Inhibition of STAT3 signaling reduces IgA1 autoantigen production in IgA nephropathy, Kidney Int Rep, 2, 1194, 10.1016/j.ekir.2017.07.002 Vouri, 2016, Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells, Oncogenesis, 5, e266, 10.1038/oncsis.2016.66 Holland, 2010, R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer, Cancer Res, 70, 1544, 10.1158/0008-5472.CAN-09-2997 Ghosh, 2011, The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy, Blood, 117, 1928, 10.1182/blood-2010-09-305649 Chen, 2013, Platelet-derived growth factors and their receptors: structural and functional perspectives, Biochim Biophys Acta, 1834, 2176, 10.1016/j.bbapap.2012.10.015 Antony, 2017, AXL-driven EMT state as a targetable conduit in cancer, Cancer Res, 77, 3725, 10.1158/0008-5472.CAN-17-0392 Lu, 2017, Single-cell RNA-sequence analysis of mouse glomerular mesangial cells uncovers mesangial cell essential genes, Kidney Int, 92, 504, 10.1016/j.kint.2017.01.016 Wang, 2014, The capable ABL: what is its biological function?, Mol Cell Biol, 34, 1188, 10.1128/MCB.01454-13 Hoj, 2019, A TAZ-AXL-ABL2 feed-forward signaling axis promotes lung adenocarcinoma brain metastasis, Cell Rep, 29, 3421, 10.1016/j.celrep.2019.11.018 Yeh, 2011, Transcriptional activation of the Axl and PDGFR-alpha by c-Met through a ras- and Src-independent mechanism in human bladder cancer, BMC Cancer, 11, 139, 10.1186/1471-2407-11-139 Gujral, 2013, Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays, Oncogene, 32, 3470, 10.1038/onc.2012.378 Salian-Mehta, 2013, AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival, Mol Cell Endocrinol, 374, 92, 10.1016/j.mce.2013.04.018 Revach, 2019, Cross-talk between receptor tyrosine kinases AXL and ERBB3 regulates invadopodia formation in melanoma cells, Cancer Res, 79, 2634, 10.1158/0008-5472.CAN-18-2316 Guo, 2008, Signaling networks assembled by oncogenic EGFR and c-Met, Proc Natl Acad Sci U S A, 105, 692, 10.1073/pnas.0707270105 Sirvent, 2008, Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells, Biol Cell, 100, 617, 10.1042/BC20080020 Volinsky, 2013, Complexity of receptor tyrosine kinase signal processing, Cold Spring Harb Perspect Biol, 5, a009043, 10.1101/cshperspect.a009043 Shi, 2018, Caught in the “Akt”: cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF, Sci Signal, 11, 10.1126/scisignal.aau1207 Stallaert, 2018, Contact inhibitory Eph signaling suppresses EGF-promoted cell migration by decoupling EGFR activity from vesicular recycling, Sci Signal, 11, 10.1126/scisignal.aat0114 Li, 2017, Increased Mer and Axl receptor tyrosine kinase expression on glomeruli in lupus nephritis, Clin Rheumatol, 36, 1063, 10.1007/s10067-017-3550-8 Orme, 2016, Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE, Clin Immunol, 169, 58, 10.1016/j.clim.2016.05.011 Parodis, 2019, Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis, PLoS One, 14, 10.1371/journal.pone.0212068 Dangi, 2020, Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection, JCI Insight, 5, 10.1172/jci.insight.141321 Zhen, 2018, Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis, J Autoimmun, 93, 37, 10.1016/j.jaut.2018.06.001 Landolt, 2019, AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction, Physiol Rep, 7, 10.14814/phy2.14091 Chen, 2019, Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFkappaB/Nrf2 axis, Free Radic Biol Med, 134, 484, 10.1016/j.freeradbiomed.2019.01.046 Kurata, 2020, Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells, PLoS One, 15, 10.1371/journal.pone.0232055